This study evaluates the effect of resin infiltration on dental sensitivity, quality of life, and satisfaction in children aged 7-14 with enamel defects in their front teeth. Forty children received treatment, and outcomes were measured through sensitivity tests and questionnaires for both children and parents.
Developmental enamel defects can negatively impact oral health-related quality of life by causing esthetic concerns and dental hypersensitivity in children. This prospective clinical study included 40 children aged 7-14 years diagnosed with hypomineralization or hypoplasia in their anterior teeth. All participants received resin infiltration treatment. Dental hypersensitivity was evaluated pre- and post-treatment using the Schiff Cold Air Sensitivity Scale (SCASS). Oral health-related quality of life was assessed using the Pediatric Oral Health-Related Quality of Life (POQL) scale through both child and parent forms. Post-treatment esthetic satisfaction levels were recorded based on reports from both children and their parents. The study aimed to determine the impact of resin infiltration on improving sensitivity, quality of life, and satisfaction in this population.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Application of a low-viscosity resin infiltrant to the anterior teeth affected by enamel defects. This procedure aims to reduce dental hypersensitivity and improve esthetic appearance.
Inonu University
Malatya, Battalgazi, Turkey (Türkiye)
Change in Dental Hypersensitivity and Patient-Parent Satisfaction
Dental hypersensitivity will be assessed using the Schiff Cold Air Sensitivity Scale (SCASS) before treatment and at 1, 3, and 6 months post-treatment, where higher scores indicate greater sensitivity. Patient and parent satisfaction regarding esthetic and functional outcomes will be measured through standardized questionnaires administered after treatment. Schiff Cold Air Sensitivity Scale (SCASS): 0 - The patient does not respond to the air stimulus. 1. \- The patient is aware of the stimulus but does not indicate discomfort and does not request discontinuation. 2. \- The patient responds to the stimulus with clear discomfort and requests discontinuation, either verbally or by turning the head. 3. \- The patient responds to the stimulus with pain and immediately and clearly requests discontinuation.
Time frame: Baseline, 1 month, 3 months, and 6 months after treatment
Change in Dental Hypersensitivity and Patient-Parent Satisfaction
Dental hypersensitivity will be assessed using the Schiff Cold Air Sensitivity Scale (SCASS) before treatment and at 1, 3, and 6 months post-treatment, where higher scores indicate greater sensitivity. Patient and parent satisfaction regarding esthetic and functional outcomes will be measured through standardized questionnaires administered after treatment. Schiff Cold Air Sensitivity Scale (SCASS): 0 - The patient does not respond to the air stimulus. 1. \- The patient is aware of the stimulus but does not indicate discomfort and does not request discontinuation. 2. \- The patient responds to the stimulus with clear discomfort and requests discontinuation, either verbally or by turning the head. 3. \- The patient responds to the stimulus with pain and immediately and clearly requests discontinuation.
Time frame: 1 month, 3 months, and 6 months after treatment
ral Health-Related Quality of Life, Esthetic Evaluation, Treatment Compliance
Oral health-related quality of life (OHRQoL) will be measured using the Pediatric Oral Health-Related Quality of Life (POQL) scale completed by both children and their parents before treatment and at follow-up visits. POQL scores will be calculated on a 0-100 scale, with higher scores indicating a lower quality of life. Esthetic changes will be assessed via clinical evaluations and patient/parent satisfaction surveys. Treatment compliance and acceptability will be recorded during the intervention process. Any adverse effects or complications following resin infiltration treatment will be monitored and documented throughout the study period.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline, 1 month, 3 months, and 6 months after treatment